129 related articles for article (PubMed ID: 6788925)
1. Hyperammonemia with valproic acid therapy.
Coulter DL; Allen RJ
J Pediatr; 1981 Aug; 99(2):317-9. PubMed ID: 6788925
[No Abstract] [Full Text] [Related]
2. Valproic acid and secondary hyperammonemia.
Rawat S; Borkowski WJ; Swick HM
Neurology; 1981 Sep; 31(9):1173-4. PubMed ID: 6791053
[TBL] [Abstract][Full Text] [Related]
3. Valproate-associated hyperammonemia and DL-carnitine supplement.
Komatsu M; Kodama S; Yokoyama S; Konishi H; Tanaka K; Momota K; Wada H; Matsuo T
Kobe J Med Sci; 1987 Jun; 33(3):81-7. PubMed ID: 2959815
[No Abstract] [Full Text] [Related]
4. Asymptomatic hyperammonemia in patients receiving valproic acid.
Murphy JV; Marquardt K
Arch Neurol; 1982 Sep; 39(9):591-2. PubMed ID: 6810855
[TBL] [Abstract][Full Text] [Related]
5. Carnitine deficiency and hyperammonemia associated with valproic acid therapy.
Ohtani Y; Endo F; Matsuda I
J Pediatr; 1982 Nov; 101(5):782-5. PubMed ID: 6813444
[TBL] [Abstract][Full Text] [Related]
6. Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient.
Kulick SK; Kramer DA
Ann Emerg Med; 1993 Mar; 22(3):610-2. PubMed ID: 8192712
[TBL] [Abstract][Full Text] [Related]
7. Hyperaminoacidemia in epileptic children treated with valproic acid.
Castro-Gago M; Rodrigo-Saez E; Novo-Rodriguez I; Camiña MF; Rodriguez-Segade S
Childs Nerv Syst; 1990 Dec; 6(8):434-6. PubMed ID: 2095300
[TBL] [Abstract][Full Text] [Related]
8. Nondosage-dependent valproic acid-induced hyperammonemia and coma.
Gaskins JD; Holt RJ; Postelnick M
Clin Pharm; 1984; 3(3):313-6. PubMed ID: 6428801
[No Abstract] [Full Text] [Related]
9. Asymptomatic hyperammonemia in children treated with valproic acid.
Altunbaşak S; Baytok V; Tasouji M; Hergüner O; Burgut R; Kayrin L
J Child Neurol; 1997 Oct; 12(7):461-3. PubMed ID: 9373804
[No Abstract] [Full Text] [Related]
10. Carnitine for valproic acid-induced hyperammonemia.
Raby WN
Am J Psychiatry; 1997 Aug; 154(8):1168-9. PubMed ID: 9247410
[No Abstract] [Full Text] [Related]
11. Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
Inoue K; Takahashi T; Yamamoto Y; Suzuki E; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
Seizure; 2015 Dec; 33():76-80. PubMed ID: 26599579
[TBL] [Abstract][Full Text] [Related]
12. [Carglumic acid for treatment of valproic acid-induced hyperammonaemia in a paediatric patient].
Gramage Caro T; Vélez-Díaz-Pallarés M; Serna Pérez J; Bermejo Vicedo T
Farm Hosp; 2012; 36(5):437-8. PubMed ID: 22858088
[No Abstract] [Full Text] [Related]
13. Valproate-induced hyperammonemia in asymptomatic children.
Wyllie E; Wyllie R; Rothner AD; Erenberg G; Cruse RP
Cleve Clin Q; 1983; 50(3):275-7. PubMed ID: 6418412
[No Abstract] [Full Text] [Related]
14. [The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia].
Matsui K; Iwamoto H; Ohtsuki N; Kobayashi T; Miyake S; Yamada M
No To Hattatsu; 1991 Jan; 23(1):32-8. PubMed ID: 1825272
[TBL] [Abstract][Full Text] [Related]
15. [Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?].
Ettlin T; Scollo-Lavizzari G
Schweiz Rundsch Med Prax; 1986 Jul; 75(29):881-5. PubMed ID: 3090672
[No Abstract] [Full Text] [Related]
16. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
[TBL] [Abstract][Full Text] [Related]
17. [Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate].
Mattei A; Bernard G; Plauchu G; Paliard P
Gastroenterol Clin Biol; 1993; 17(6-7):516-7. PubMed ID: 8243949
[No Abstract] [Full Text] [Related]
18. [Hyperammonemia in valproate therapy in children and adolescents].
Laub MC
Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461
[TBL] [Abstract][Full Text] [Related]
19. Hyperammonemia and asterixis with valproic acid.
Coulter D
Neurology; 1981 Dec; 31(12):1580. PubMed ID: 6796907
[No Abstract] [Full Text] [Related]
20. Serum biotinidase activity in children treated with valproic acid and carbamazepine.
Castro-Gago M; Gómez-Lado C; Eirís-Puñal J; Díaz-Mayo I; Castiñeiras-Ramos DE
J Child Neurol; 2010 Jan; 25(1):32-5. PubMed ID: 19458381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
